Device Vte

Ct Thrombectomy System Kit

Payments companies reported to CMS as associated with Ct Thrombectomy System Kit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$17Massociated payments (2023-2025)
26,364clinicians with associated payments
2companies reporting

By year

2023 $6.6M
2024 $6.7M
2025 $3.5M

Payments reported as associated with Ct Thrombectomy System Kit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $3.8M
Vascular Surgery $2.6M
Interventional Cardiology $2.4M
Diagnostic Radiology $1.7M
Cardiovascular Disease $1.1M
Emergency Medicine $927K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ct Thrombectomy System Kit

These are the largest totals companies reported as associated with Ct Thrombectomy System Kit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Alexander Misono Newport Beach, CA Vascular & Interventional Radiology $702,125.22
Nicolas Mouawad West Branch, MI Vascular Surgery $373,108.79
Ripal Gandhi Miami, FL Vascular & Interventional Radiology $343,347.87
Steven Abramowitz Washington, DC Vascular Surgery $295,270.69
Peter Farrugia Colts Neck, NJ Cardiovascular Disease $276,000.00
Herman Kado Southfield, MI Cardiovascular Disease $271,436.23
Jason Berger Clearwater, FL Physician Assistant $254,930.67
Abdullah Shaikh Pittsburgh, PA Vascular & Interventional Radiology $226,782.37
Trevor Cummings Grand Rapids, MI Emergency Medicine $226,042.39
Raja Ramaswamy Indianapolis, IN Diagnostic Radiology $219,242.07

Prescribed Ct Thrombectomy System Kit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.